☰

Angeline S. Andrew, Ph.D. - Publications

Affiliations: 
2001 Dartmouth College, Hanover, NH, United States 
Area:
Toxicology
Tree Info Similar researchers PubMed Report error

93 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sun R, Xu M, Li X, Gaynor S, Zhou H, Li Z, Bossé Y, Lam S, Tsao MS, Tardon A, Chen C, Doherty J, Goodman G, Bojesen SE, Landi MT, ... ... Andrew A, et al. Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer. Genetic Epidemiology. PMID 32924180 DOI: 10.1002/Gepi.22358  0.404
2020 Zhou W, Liu G, Hung RJ, Haycock PC, Aldrich MC, Andrew AS, Arnold SM, Bickeböller H, Bojesen SE, Brennan P, Brunnström H, Melander O, Caporaso NE, Landi MT, Chen C, et al. Causal Relationships between Body Mass Index, Smoking, and Lung Cancer: Univariable and Multivariable Mendelian Randomization. International Journal of Cancer. PMID 32914876 DOI: 10.1002/Ijc.33292  0.369
2020 Shee K, Seigne JD, Karagas MR, Marsit CJ, Hinds JW, Schned AR, Pettus JR, Armstrong DA, Miller TW, Andrew AS. Identification of let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancer. Cancer Biomarkers : Section a of Disease Markers. PMID 32623385 DOI: 10.3233/Cbm-191322  0.307
2020 Ji X, Mukherjee S, Landi MT, Bosse Y, Joubert P, Zhu D, Gorlov I, Xiao X, Han Y, Gorlova O, Hung RJ, Brhane Y, Carreras-Torres R, Christiani DC, Caporaso N, ... ... Andrew AS, et al. Protein-altering germline mutations implicate novel genes related to lung cancer development. Nature Communications. 11: 2220. PMID 32393777 DOI: 10.1038/S41467-020-15905-6  0.409
2020 Wang Y, Gorlova OY, Gorlov IP, Zhu M, Dai J, Albanes D, Lam S, Tardon A, Chen C, Goodman GE, Bojesen SE, Landi MT, Johansson M, Risch A, Wichmann HE, ... ... Andrew AS, et al. Association analysis of driver-gene related genetic variants identified novel lung cancer susceptibility loci with 20,871 lung cancer cases and 15,971 controls. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32277007 DOI: 10.1158/1055-9965.Epi-19-1085  0.306
2019 Bossé Y, Li Z, Xia J, Manem V, Carreras-Torres R, Gabriel A, Gaudreault N, Albanes D, Aldrich MC, Andrew A, Arnold S, Bickeböller H, Bojesen SE, Brennan P, Brunnstrom H, et al. Transcriptome-wide association study reveals candidate causal genes for lung cancer. International Journal of Cancer. PMID 31696517 DOI: 10.1002/Ijc.32771  0.316
2019 Li Y, Xiao X, Bossé Y, Gorlova O, Gorlov I, Han Y, Byun J, Leighl N, Johansen JS, Barnett M, Chen C, Goodman G, Cox A, Taylor F, Woll P, ... ... Andrew AS, et al. Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development. Oncotarget. 10: 1760-1774. PMID 30956756 DOI: 10.18632/Oncotarget.26678  0.31
2018 Dai J, Li Z, Amos CI, Hung RJ, Tardon A, Andrew A, Chen C, Christiani DC, Albanes D, van der Heijden EHFM, Duell E, Rennert G, James MD, Yuan JM, Field JK, et al. Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci. Carcinogenesis. PMID 30590402 DOI: 10.1093/Carcin/Bgy187  0.322
2018 Brenner DR, Fehringer G, Zhang ZF, Lee YA, Meyers T, Matsuo K, Ito H, Vineis P, Stucker I, Boffetta P, Brennan P, Christiani DC, Diao N, Hong YC, Landi MT, ... ... Andrew AS, et al. Alcohol consumption and lung cancer risk: A pooled analysis from the International Lung Cancer Consortium and the SYNERGY study. Cancer Epidemiology. 58: 25-32. PMID 30445228 DOI: 10.1016/J.Canep.2018.10.006  0.373
2018 Andrew AS, Parker S, Anderson JC, Rees JR, Robinson C, Riddle B, Butterly LF. Risk Factors for Diagnosis of Colorectal Cancer at a Late Stage: a Population-Based Study. Journal of General Internal Medicine. PMID 30284171 DOI: 10.1007/S11606-018-4648-7  0.318
2018 Ferreiro-Iglesias A, Lesseur C, McKay J, Hung RJ, Han Y, Zong X, Christiani D, Johansson M, Xiao X, Li Y, Qian DC, Ji X, Liu G, Caporaso N, Scelo G, ... ... Andrew A, et al. Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. Nature Communications. 9: 3927. PMID 30254314 DOI: 10.1038/S41467-018-05890-2  0.366
2018 Facciponte DN, Bough MW, Seidler D, Carroll JL, Ashare A, Andrew AS, Tsongalis GJ, Vaickus LJ, Henegan PL, Butt TH, Stommel EW. Identifying aerosolized cyanobacteria in the human respiratory tract: A proposed mechanism for cyanotoxin-associated diseases. The Science of the Total Environment. 645: 1003-1013. PMID 30248825 DOI: 10.1016/J.Scitotenv.2018.07.226  0.314
2018 Kachuri L, Saarela O, Bojesen SE, Davey Smith G, Liu G, Landi MT, Caporaso NE, Christiani DC, Johansson M, Panico S, Overvad K, Trichopoulou A, Vineis P, Scelo G, Zaridze D, ... ... Andrew AS, et al. Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers. International Journal of Epidemiology. PMID 30059977 DOI: 10.1093/Ije/Dyy140  0.371
2017 Ben Khedher S, Neri M, Papadopoulos A, Christiani DC, Diao N, Harris CC, Olivo-Marston S, Schwartz AG, Cote M, Koushik A, Siemiatycki J, Landi MT, Hung RJ, McLaughlin J, Duell EJ, ... Andrew AS, et al. Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the International Lung Cancer consortium (ILCCO). International Journal of Cancer. PMID 28440542 DOI: 10.1002/Ijc.30750  0.389
2017 Andrew AS, Baron JA, Butterly LF, Suriawinata AA, Tsongalis GJ, Robinson CM, Amos CI. Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers. International Journal of Molecular Sciences. 18. PMID 28257124 DOI: 10.3390/Ijms18030535  0.314
2017 Fehringer G, Brenner DR, Zhang ZF, Lee YA, Matsuo K, Ito H, Lan Q, Vineis P, Johansson M, Overvad K, Riboli E, Trichopoulou A, Sacerdote C, Stucker I, Boffetta P, ... ... Andrew AS, et al. Alcohol and Lung Cancer Risk Among Never Smokers: A Pooled Analysis from the International Lung Cancer Consortium and the SYNERGY Study. International Journal of Cancer. PMID 28120396 DOI: 10.1002/Ijc.30618  0.355
2017 Kachuri L, Johansson M, Brennan P, Haycock P, Liu G, Landi MT, Christiani DC, Caporaso NE, Wu X, Aldrich MC, Albanes D, Tardón A, Rennert G, Chen C, Goodman GE, ... ... Andrew AS, et al. Abstract 2292: Lung function and lung cancer risk: a Mendelian randomization study of UK Biobank cohort and the International Lung Cancer Consortium Epidemiology. 77: 2292-2292. DOI: 10.1158/1538-7445.Am2017-2292  0.364
2016 Cheng S, Andrew AS, Andrews PC, Moore JH. Complex systems analysis of bladder cancer susceptibility reveals a role for decarboxylase activity in two genome-wide association studies. Biodata Mining. 9: 40. PMID 27999618 DOI: 10.1186/S13040-016-0119-Z  0.342
2016 Chen LS, Baker T, Hung RJ, Horton A, Culverhouse R, Hartz S, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kim C, Rosenberger A, Aben KK, ... Andrew AS, et al. Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis. Ebiomedicine. 11: 219-226. PMID 27543155 DOI: 10.1016/J.Ebiom.2016.08.012  0.341
2016 Kachuri L, Smith GD, Liu G, Landi MT, Christiani DC, Caporaso NE, McKay JD, Wu X, Aldrich MC, Rennert G, Teare D, Chen C, Goodman GE, Doherty JA, Field JK, ... ... Andrew AS, et al. Abstract 817: Mendelian randomization and mediation analysis of 5p15.33, telomere length and lung cancer risk Cancer Research. 76: 817-817. DOI: 10.1158/1538-7445.Am2016-817  0.412
2015 Huang R, Wei Y, Hung RJ, Liu G, Su L, Zhang R, Zong X, Zhang ZF, Morgenstern H, Brüske I, Heinrich J, Hong YC, Kim JH, Cote M, Wenzlaff A, ... ... Andrew AS, et al. Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. Ebiomedicine. 2: 1677-1685. PMID 26870794 DOI: 10.1016/J.Ebiom.2015.09.031  0.379
2015 Hu S, Danilov AV, Godek K, Orr B, Tafe LJ, Rodriguez-Canales J, Behrens C, Mino B, Moran CA, Memoli VA, Mustachio LM, Galimberti F, Ravi S, DeCastro A, Lu Y, ... ... Andrew AS, et al. CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110. Cancer Research. 75: 2029-38. PMID 25808870 DOI: 10.1158/0008-5472.Can-14-1494  0.394
2015 Andrew AS, Gui J, Hu T, Wyszynski A, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Ekstrom RM, Li Z, Zens MS, Borsuk M, Moore JH, Karagas MR. Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study. Bju International. 115: 238-47. PMID 24666523 DOI: 10.1111/Bju.12641  0.369
2014 Hu T, Pan Q, Andrew AS, Langer JM, Cole MD, Tomlinson CR, Karagas MR, Moore JH. Functional genomics annotation of a statistical epistasis network associated with bladder cancer susceptibility. Biodata Mining. 7: 5. PMID 24725556 DOI: 10.1186/1756-0381-7-5  0.425
2014 Kim CH, Lee YC, Hung RJ, McNallan SR, Cote ML, Lim WY, Chang SC, Kim JH, Ugolini D, Chen Y, Liloglou T, Andrew AS, Onega T, Duell EJ, Field JK, et al. Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). International Journal of Cancer. Journal International Du Cancer. 135: 1918-30. PMID 24615328 DOI: 10.1002/Ijc.28835  0.374
2014 Pan Q, Hu T, Malley JD, Andrew AS, Karagas MR, Moore JH. A system-level pathway-phenotype association analysis using synthetic feature random forest. Genetic Epidemiology. 38: 209-19. PMID 24535726 DOI: 10.1002/Gepi.21794  0.331
2014 Wyszynski A, Tanyos SA, Rees JR, Marsit CJ, Kelsey KT, Schned AR, Pendleton EM, Celaya MO, Zens MS, Karagas MR, Andrew AS. Body mass and smoking are modifiable risk factors for recurrent bladder cancer. Cancer. 120: 408-14. PMID 24122218 DOI: 10.1002/Cncr.28394  0.331
2014 Hu S, Danilov AV, Godek KM, Orr B, Tafe LJ, Memoli VA, Galimberti F, Ravi S, DeCastro AJ, Lu Y, Mustachio LM, Sekula DJ, Andrew AS, Freemantle SJ, Compton DA, et al. Abstract 4549: CDK2 inhibition causes anaphase catastrophe through the centrosomal protein CP110 Cancer Research. 74: 4549-4549. DOI: 10.1158/1538-7445.Am2014-4549  0.401
2014 Fehringer G, Brenner D, Zhang Z, Lee YA, Matsuo K, Stucker I, Vineis P, Boffetta P, Brennan P, Landi MT, Morgenstern H, Harris CC, Lan Q, Hong Y, Siemiatycki J, ... ... Andrew AS, et al. Abstract 1274: Alcohol and lung cancer risk: a pooled analysis using International Lung Cancer Consortium studies Cancer Research. 74: 1274-1274. DOI: 10.1158/1538-7445.Am2014-1274  0.356
2013 Pesatori AC, Carugno M, Consonni D, Hung RJ, Papadoupolos A, Landi MT, Brenner H, Müller H, Harris CC, Duell EJ, Andrew AS, McLaughlin JR, Schwartz AG, Wenzlaff AS, Stucker I. Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO). British Journal of Cancer. 109: 1954-64. PMID 24002594 DOI: 10.1038/Bjc.2013.506  0.363
2013 Sacerdote C, Guarrera S, Ricceri F, Pardini B, Polidoro S, Allione A, Critelli R, Russo A, Andrew AS, Ye Y, Wu X, Kiemeney LA, Bosio A, Casetta G, Cucchiarale G, et al. Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy. International Journal of Cancer. 133: 2004-9. PMID 23553206 DOI: 10.1002/Ijc.28186  0.335
2013 Urbanowicz RJ, Andrew AS, Karagas MR, Moore JH. Role of genetic heterogeneity and epistasis in bladder cancer susceptibility and outcome: a learning classifier system approach. Journal of the American Medical Informatics Association : Jamia. 20: 603-12. PMID 23444013 DOI: 10.1136/Amiajnl-2012-001574  0.316
2012 Schned AR, Lenz P, Moore LE, Johnson A, Jones M, Kida M, Silverman DT, Schwenn M, Kelsey KT, Andrew AS, Baris D, Karagas MR. Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004. Isrn Pathology. 2012. PMID 24683496 DOI: 10.5402/2012/283670  0.317
2012 Sloan CD, Andrew AS, Gruber JF, Mwenda KM, Moore JH, Onega T, Karagas MR, Shi X, Duell EJ. Indoor and Outdoor Air Pollution and Lung Cancer in New Hampshire and Vermont. Toxicological and Environmental Chemistry. 94. PMID 24273369 DOI: 10.1080/02772248.2012.659930  0.383
2012 Andrew AS, Hu T, Gu J, Gui J, Ye Y, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Mason RA, Morlock EV, Zens MS, Li Z, Moore JH, et al. HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer. Plos One. 7: e51301. PMID 23284679 DOI: 10.1371/Journal.Pone.0051301  0.407
2012 Brenner DR, Boffetta P, Duell EJ, Bickeböller H, Rosenberger A, McCormack V, Muscat JE, Yang P, Wichmann HE, Brueske-Hohlfeld I, Schwartz AG, Cote ML, Tjønneland A, Friis S, Le Marchand L, ... ... Andrew AS, et al. Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. American Journal of Epidemiology. 176: 573-85. PMID 22986146 DOI: 10.1093/Aje/Kws151  0.38
2012 Galimberti F, Busch AM, Chinyengetere F, Ma T, Sekula D, Memoli VA, Dragnev KH, Liu F, Johnson KC, Guo Y, Freemantle SJ, Andrew AS, Greninger P, Robbins DJ, Settleman J, et al. Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations. International Journal of Oncology. 41: 1751-61. PMID 22923130 DOI: 10.3892/Ijo.2012.1599  0.419
2012 Ma J, Xiao F, Xiong M, Andrew AS, Brenner H, Duell EJ, Haugen A, Hoggart C, Hung RJ, Lazarus P, Liu C, Matsuo K, Mayordomo JI, Schwartz AG, Staratschek-Jox A, et al. Natural and orthogonal interaction framework for modeling gene-environment interactions with application to lung cancer. Human Heredity. 73: 185-94. PMID 22889990 DOI: 10.1159/000339906  0.349
2012 Guo Y, Chinyengetere F, Dolinko AV, Lopez-Aguiar A, Lu Y, Galimberti F, Ma T, Feng Q, Sekula D, Freemantle SJ, Andrew AS, Memoli V, Dmitrovsky E. Evidence for the ubiquitin protease UBP43 as an antineoplastic target. Molecular Cancer Therapeutics. 11: 1968-77. PMID 22752428 DOI: 10.1158/1535-7163.Mct-12-0248  0.355
2012 Coté ML, Liu M, Bonassi S, Neri M, Schwartz AG, Christiani DC, Spitz MR, Muscat JE, Rennert G, Aben KK, Andrew AS, Bencko V, Bickeböller H, Boffetta P, Brennan P, et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. European Journal of Cancer (Oxford, England : 1990). 48: 1957-68. PMID 22436981 DOI: 10.1016/J.Ejca.2012.01.038  0.375
2012 Lesseur C, Gilbert-Diamond D, Andrew AS, Ekstrom RM, Li Z, Kelsey KT, Marsit CJ, Karagas MR. A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire. Toxicology Letters. 210: 100-6. PMID 22306368 DOI: 10.1016/J.Toxlet.2012.01.015  0.404
2012 Rosenberger A, Bickeböller H, McCormack V, Brenner DR, Duell EJ, Tjønneland A, Friis S, Muscat JE, Yang P, Wichmann HE, Heinrich J, Szeszenia-Dabrowska N, Lissowska J, Zaridze D, Rudnai P, ... ... Andrew AS, et al. Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. Carcinogenesis. 33: 587-97. PMID 22198214 DOI: 10.1093/Carcin/Bgr307  0.345
2012 Fan R, Zhong M, Wang S, Zhang Y, Andrew A, Karagas M, Chen H, Amos CI, Xiong M, Moore JH. Entropy-based information gain approaches to detect and to characterize gene-gene and gene-environment interactions/correlations of complex diseases. Genetic Epidemiology. 35: 706-21. PMID 22009792 DOI: 10.1002/Gepi.20621  0.338
2012 Karagas MR, Andrew AS, Nelson HH, Li Z, Punshon T, Schned A, Marsit CJ, Morris JS, Moore JH, Tyler AL, Gilbert-Diamond D, Guerinot ML, Kelsey KT. SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer. Human Genetics. 131: 453-61. PMID 21947419 DOI: 10.1007/S00439-011-1090-X  0.371
2011 McCormack VA, Hung RJ, Brenner DR, Bickeböller H, Rosenberger A, Muscat JE, Lazarus P, Tjønneland A, Friis S, Christiani DC, Chun EM, Le Marchand L, Rennert G, Rennert HS, Andrew AS, et al. Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO). Cancer Causes & Control : Ccc. 22: 1709-20. PMID 21987079 DOI: 10.1007/S10552-011-9847-Z  0.371
2011 Hu T, Sinnott-Armstrong NA, Kiralis JW, Andrew AS, Karagas MR, Moore JH. Characterizing genetic interactions in human disease association studies using statistical epistasis networks. Bmc Bioinformatics. 12: 364. PMID 21910885 DOI: 10.1186/1471-2105-12-364  0.319
2011 Gui J, Andrew AS, Andrews P, Nelson HM, Kelsey KT, Karagas MR, Moore JH. A robust multifactor dimensionality reduction method for detecting gene-gene interactions with application to the genetic analysis of bladder cancer susceptibility. Annals of Human Genetics. 75: 20-8. PMID 21091664 DOI: 10.1111/J.1469-1809.2010.00624.X  0.354
2011 Gui J, Moore JH, Kelsey KT, Marsit CJ, Karagas MR, Andrew AS. A novel survival multifactor dimensionality reduction method for detecting gene-gene interactions with application to bladder cancer prognosis. Human Genetics. 129: 101-10. PMID 20981448 DOI: 10.1007/S00439-010-0905-5  0.315
2011 Andrew AS, Gui J, Moore JH, Karagas MR, Pendleton E, Schned AR, Mason RA, Wyszynski A, Tanyos SA, Kelsey KT, Marsit CJ, Zens MS. Abstract A66: Apoptosis, cell cycle, DNA repair, immune, and metabolism pathway SNPs modify bladder cancer risk, recurrence, and survival Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A66  0.384
2011 Guo Y, Chinyengetere F, Dolinko AV, Lopez-Aguiar A, Galimberti F, Ma T, Feng Q, Andrew AS, Sekula D, Freemantle S, Memoli V, Dmitrovsky E. Abstract 1655: The ubiquitin protease UBP43 is a target for lung cancer therapy and prevention Cancer Research. 71: 1655-1655. DOI: 10.1158/1538-7445.Am2011-1655  0.391
2011 Galimberti F, Busch A, Chinyengetere F, Ma T, Sekula D, Memoli V, Dragnev K, Liu F, Andrew AS, Greninger P, Robbins D, Settleman J, Benes C, Dmitrovsky E. Abstract 1615: Gene expression profile predicts response to smoothened inhibitors in epithelial cancers Cancer Research. 71: 1615-1615. DOI: 10.1158/1538-7445.Am2011-1615  0.392
2011 Karagas M, Andrew A, Nelson H, Schned A, Marsit C, Morris JS, Moore J, Punshon T, Guerinot ML, Kelsey K. Novel Single Nucleotide Polymorphisms Related to Arsenic-associated Bladder Cancer in a US Population-based Study Epidemiology. 22: S71. DOI: 10.1097/01.Ede.0000391881.64955.15  0.34
2010 Gui J, Andrew AS, Andrews P, Nelson HM, Kelsey KT, Karagas MR, Moore JH. A simple and computationally efficient sampling approach to covariate adjustment for multifactor dimensionality reduction analysis of epistasis. Human Heredity. 70: 219-25. PMID 20924193 DOI: 10.1159/000319175  0.32
2010 Hosgood HD, Boffetta P, Greenland S, Lee YC, McLaughlin J, Seow A, Duell EJ, Andrew AS, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Fabiánová E, Mates D, Bencko V, et al. In-home coal and wood use and lung cancer risk: a pooled analysis of the International Lung Cancer Consortium. Environmental Health Perspectives. 118: 1743-7. PMID 20846923 DOI: 10.1289/Ehp.1002217  0.353
2010 Marsit CJ, Houseman EA, Christensen BC, Gagne L, Wrensch MR, Nelson HH, Wiemels J, Zheng S, Wiencke JK, Andrew AS, Schned AR, Karagas MR, Kelsey KT. Identification of methylated genes associated with aggressive bladder cancer. Plos One. 5: e12334. PMID 20808801 DOI: 10.1371/Journal.Pone.0012334  0.354
2010 Truong T, Hung RJ, Amos CI, Wu X, Bickeböller H, Rosenberger A, Sauter W, Illig T, Wichmann HE, Risch A, Dienemann H, Kaaks R, Yang P, Jiang R, Wiencke JK, ... ... Andrew AS, et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. Journal of the National Cancer Institute. 102: 959-71. PMID 20548021 DOI: 10.1093/Jnci/Djq178  0.372
2010 Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Li H, Direnzo J, Bak M, Freemantle SJ, et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. The Journal of Clinical Investigation. 120: 1298-309. PMID 20237410 DOI: 10.1172/Jci39566  0.317
2010 Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, Zens MS, Andrew AS, Morris S, Nelson HH, Schned AR, Karagas MR, Marsit CJ. Implications of LINE1 methylation for bladder cancer risk in women. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1682-9. PMID 20179218 DOI: 10.1158/1078-0432.Ccr-09-2983  0.305
2010 Truong T, Sauter W, McKay JD, Hosgood HD, Gallagher C, Amos CI, Spitz M, Muscat J, Lazarus P, Illig T, Wichmann HE, Bickeböller H, Risch A, Dienemann H, Zhang ZF, ... ... Andrew AS, et al. International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants. Carcinogenesis. 31: 625-33. PMID 20106900 DOI: 10.1093/Carcin/Bgq001  0.425
2010 Kwong RC, Karagas MR, Kelsey KT, Mason RA, Tanyos SA, Schned AR, Marsit CJ, Andrew AS. Arsenic exposure predicts bladder cancer survival in a US population. World Journal of Urology. 28: 487-92. PMID 19834714 DOI: 10.1007/S00345-009-0477-Y  0.369
2010 Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Liu H, DiRenzo J, Bak M, Kauppinen S, et al. Abstract 5698: MicroRNA-31 acts as an oncomir in lung cancer by repressing specific tumor suppressors Cancer Research. 70: 5698-5698. DOI: 10.1158/1538-7445.Am10-5698  0.326
2009 Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR, Duell EJ. Lung cancer in a U.S. population with low to moderate arsenic exposure. Environmental Health Perspectives. 117: 1718-23. PMID 20049123 DOI: 10.1289/Ehp.0900566  0.335
2009 Stern MC, Lin J, Figueroa JD, Kelsey KT, Kiltie AE, Yuan JM, Matullo G, Fletcher T, Benhamou S, Taylor JA, Placidi D, Zhang ZF, Steineck G, Rothman N, Kogevinas M, ... ... Andrew AS, et al. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Research. 69: 6857-64. PMID 19706757 DOI: 10.1158/0008-5472.Can-09-1091  0.368
2009 Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G, Seminara D, Yoshida T, Saeki N, Andrew AS, Dinney CP, Czerniak B, Zhang ZF, Kiltie AE, Bishop DT, et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nature Genetics. 41: 991-5. PMID 19648920 DOI: 10.1038/Ng.421  0.353
2009 Andrew AS, Mason RA, Kelsey KT, Schned AR, Marsit CJ, Nelson HH, Karagas MR. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Toxicology Letters. 187: 10-4. PMID 19429237 DOI: 10.1016/J.Toxlet.2009.01.013  0.4
2009 Mason RA, Morlock EV, Karagas MR, Kelsey KT, Marsit CJ, Schned AR, Andrew AS. EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. Carcinogenesis. 30: 1155-60. PMID 19372140 DOI: 10.1093/Carcin/Bgp077  0.388
2009 Andrew AS, Gui J, Sanderson AC, Mason RA, Morlock EV, Schned AR, Kelsey KT, Marsit CJ, Moore JH, Karagas MR. Bladder cancer SNP panel predicts susceptibility and survival. Human Genetics. 125: 527-39. PMID 19252927 DOI: 10.1007/S00439-009-0645-6  0.391
2009 Andrew AS, Mason RA, Memoli V, Duell EJ. Arsenic activates EGFR pathway signaling in the lung. Toxicological Sciences : An Official Journal of the Society of Toxicology. 109: 350-7. PMID 19168569 DOI: 10.1093/Toxsci/Kfp015  0.361
2009 Wallace K, Kelsey KT, Schned A, Morris JS, Andrew AS, Karagas MR. Selenium and risk of bladder cancer: a population-based case-control study. Cancer Prevention Research (Philadelphia, Pa.). 2: 70-3. PMID 19139020 DOI: 10.1158/1940-6207.Capr-08-0046  0.358
2008 Hung RJ, Christiani DC, Risch A, Popanda O, Haugen A, Zienolddiny S, Benhamou S, Bouchardy C, Lan Q, Spitz MR, Wichmann HE, LeMarchand L, Vineis P, Matullo G, Kiyohara C, ... ... Andrew AS, et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3081-9. PMID 18990748 DOI: 10.1158/1055-9965.Epi-08-0411  0.394
2008 Hays AM, Lantz RC, Rodgers LS, Sollome JJ, Vaillancourt RR, Andrew AS, Hamilton JW, Camenisch TD. Arsenic-induced decreases in the vascular matrix. Toxicologic Pathology. 36: 805-17. PMID 18812580 DOI: 10.1177/0192623308323919  0.351
2008 Schned AR, Andrew AS, Marsit CJ, Kelsey KT, Zens MS, Karagas MR. Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scandinavian Journal of Urology and Nephrology. 42: 237-42. PMID 18432530 DOI: 10.1080/00365590801948166  0.317
2008 Andrew AS, Jewell DA, Mason RA, Whitfield ML, Moore JH, Karagas MR. Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environmental Health Perspectives. 116: 524-31. PMID 18414638 DOI: 10.1289/Ehp.10861  0.325
2008 Andrew AS, Karagas MR, Nelson HH, Guarrera S, Polidoro S, Gamberini S, Sacerdote C, Moore JH, Kelsey KT, Demidenko E, Vineis P, Matullo G. DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Human Heredity. 65: 105-18. PMID 17898541 DOI: 10.1159/000108942  0.34
2007 Schned AR, Andrew AS, Marsit CJ, Zens MS, Kelsey KT, Karagas MR. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems. The Journal of Urology. 178: 1196-200; discussion. PMID 17698105 DOI: 10.1016/J.Juro.2007.05.126  0.308
2007 Fortuny J, Kogevinas M, Zens MS, Schned A, Andrew AS, Heaney J, Kelsey KT, Karagas MR. Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study. Bmc Urology. 7: 13. PMID 17692123 DOI: 10.1186/1471-2490-7-13  0.302
2007 Andrew AS, Bernardo V, Warnke LA, Davey JC, Hampton T, Mason RA, Thorpe JE, Ihnat MA, Hamilton JW. Exposure to arsenic at levels found inU.S. drinking water modifies expression in the mouse lung. Toxicological Sciences : An Official Journal of the Society of Toxicology. 100: 75-87. PMID 17682005 DOI: 10.1093/Toxsci/Kfm200  0.361
2007 Karagas MR, Zens MS, Nelson HH, Mabuchi K, Perry AE, Stukel TA, Mott LA, Andrew AS, Applebaum KM, Linet M. Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage. American Journal of Epidemiology. 165: 719-26. PMID 17204514 DOI: 10.1093/Aje/Kwk055  0.31
2006 Andrew AS, Burgess JL, Meza MM, Demidenko E, Waugh MG, Hamilton JW, Karagas MR. Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environmental Health Perspectives. 114: 1193-8. PMID 16882524 DOI: 10.1289/Ehp.9008  0.328
2006 Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP, Tosteson TD, Schned AR, Karagas MR. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis. 27: 1030-7. PMID 16311243 DOI: 10.1093/Carcin/Bgi284  0.401
2005 Karagas MR, Park S, Nelson HH, Andrew AS, Mott L, Schned A, Kelsey KT. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study. International Journal of Hygiene and Environmental Health. 208: 321-7. PMID 16217917 DOI: 10.1016/J.Ijheh.2005.04.005  0.344
2005 SHMD, Hirao T, Marsit CJ, Hirao Y, Schned A, TDMS, MPHHHNPD, Andrew A, Karagas MR, MOHKTKMD. Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer Cancer. 104: 1918-1923. PMID 16149093 DOI: 10.1002/Cncr.21423  0.312
2005 Marsit CJ, Karagas MR, Andrew A, Liu M, Danaee H, Schned AR, Nelson HH, Kelsey KT. Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Research. 65: 7081-5. PMID 16103055 DOI: 10.1158/0008-5472.Can-05-0267  0.38
2005 Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH, Kelsey KT. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis. 27: 112-6. PMID 15987713 DOI: 10.1093/Carcin/Bgi172  0.406
2005 Kelsey KT, Hirao T, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Colt J, Baris D, Morris JS, Schned A, Karagas M. TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer. International Journal of Cancer. Journal International Du Cancer. 117: 370-5. PMID 15906354 DOI: 10.1002/Ijc.21195  0.386
2004 Kelsey KT, Hirao T, Schned A, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR. A population-based study of immunohistochemical detection of p53 alteration in bladder cancer. British Journal of Cancer. 90: 1572-6. PMID 15083187 DOI: 10.1038/Sj.Bjc.6601748  0.336
2004 Andrew AS, Schned AR, Heaney JA, Karagas MR. Bladder cancer risk and personal hair dye use. International Journal of Cancer. 109: 581-6. PMID 14991581 DOI: 10.1002/Ijc.11729  0.331
2003 Andrew AS, Warren AJ, Barchowsky A, Temple KA, Klei L, Soucy NV, O'Hara KA, Hamilton JW. Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environmental Health Perspectives. 111: 825-35. PMID 12760830 DOI: 10.1289/Ehp.111-1241504  0.672
2003 Andrew AS, Karagas MR, Hamilton JW. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. International Journal of Cancer. Journal International Du Cancer. 104: 263-8. PMID 12569548 DOI: 10.1002/Ijc.10968  0.344
2002 Barchowsky A, Soucy NV, O'Hara KA, Hwa J, Noreault TL, Andrew AS. A novel pathway for nickel-induced interleukin-8 expression. The Journal of Biological Chemistry. 277: 24225-31. PMID 11978798 DOI: 10.1074/Jbc.M202941200  0.667
2001 Andrew AS, Klei LR, Barchowsky A. AP-1-dependent induction of plasminogen activator inhibitor-1 by nickel does not require reactive oxygen. American Journal of Physiology. Lung Cellular and Molecular Physiology. 281: L616-23. PMID 11504688 DOI: 10.1152/Ajplung.2001.281.3.L616  0.575
2001 Andrew AS, Klei LR, Barchowsky A. Nickel requires hypoxia-inducible factor-1 alpha, not redox signaling, to induce plasminogen activator inhibitor-1. American Journal of Physiology. Lung Cellular and Molecular Physiology. 281: L607-15. PMID 11504687 DOI: 10.1152/Ajplung.2001.281.3.L607  0.562
2000 Andrew A, Barchowsky A. Nickel-induced plasminogen activator inhibitor-1 expression inhibits the fibrinolytic activity of human airway epithelial cells Toxicology and Applied Pharmacology. 168: 50-57. PMID 11000099 DOI: 10.1006/Taap.2000.9009  0.6
Show low-probability matches.